Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Patent Ductus Arteriosus: full-pipeline trial registry
1 of 8 indexed Patent Ductus Arteriosus trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 1 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Patent Ductus Arteriosus: 8 US clinical trials tracked, 1 recruiting.
Patent Ductus Arteriosus is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Florida, running 2 of these trials.
Enrollment posture brief
Registry condition patent-ductus-arteriosus
OPEN 1 | RECR 13% | LATE 1 | EARLY 1 | RANK #2176 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Respiratory Infection (13% recruiting · 8 trials)
Patent Ductus Arteriosus lists 1 open slots (13% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Patent Ductus Arteriosus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Patent Ductus Arteriosus is recruiting below its size-band peers.
1 of 8 indexed trials (12.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Patent Ductus Arteriosus research.
University of Florida accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Patent Ductus Arteriosus enrolment sits around 200 participants.
Median target enrolment is 200 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.
-
Patent Ductus Arteriosus splits between interventional and observational designs.
4 interventional and 4 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
PDA for Kidneys Study
University of Wisconsin, Madison
NCT06658496
Management of the PDA Trial
NICHD Neonatal Research Network
NCT03456336
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Nationwide Children's Hospital
NCT03782610
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
University of California, San Francisco
NCT01958320
AMPLATZER Duct Occluder II Additional Sizes
Abbott Medical Devices
NCT03055858
Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
University of Utah
NCT03551600
Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
University of Florida
NCT03277768
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
University of Florida
NCT01790750
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Patent Ductus Arteriosus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Patent Ductus Arteriosus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Patent Ductus Arteriosus page
8 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Patent Ductus Arteriosus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Florida sponsors the most Patent Ductus Arteriosus trials on record, review their full trial history before evaluating a specific study. See University of Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Patent Ductus Arteriosus condition card totals 8 registered trials; most-linked intervention Near-infrared spectroscopy (NIRS); top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.